Management of disability in lymphatic filariasis - An update

Journal of Communicable Diseases

Volumn 34, Issue 1, 2002, Pages 1-14

  Shenoy, R K ^a  

^a TD Medical College Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

FLAVANOID; PYRONE DERIVATIVE; ANTHELMINTIC AGENT;

CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY; DISEASE TRANSMISSION; ECONOMIC ASPECT; FILARIASIS; HOME CARE; HUMAN; HYDROCELE; LYMPHEDEMA; PERSONAL HYGIENE; REVIEW; WORM; ADULT; ANIMAL; CHILD; DISABLED PERSON; DISEASE MANAGEMENT; ELEPHANTIASIS; LYMPHANGITIS; PATHOGENICITY; PATHOPHYSIOLOGY; PRESCHOOL CHILD; WUCHERERIA BANCROFTI;

ADULT; ANIMALS; ANTHELMINTICS; CHILD; CHILD, PRESCHOOL; DISABLED PERSONS; DISEASE MANAGEMENT; ELEPHANTIASIS, FILARIAL; HUMANS; LYMPHANGITIS; LYMPHEDEMA; WUCHERERIA BANCROFTI;

EID: 0038389127     PISSN: 00195138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. World Health Organization. Bridging the Gaps World Health Report. WHO, Geneva. 1995.
2. Michael E, Bundy DAP and Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology 1996; 112: 409-428.
3. Ottesen EA. The human filariases: new understandings, new therapeutic strategies. Curr Opin Infect Dis 1994; 7: 550-558.
4. Centers for Disease Control and Prevention (CDC), Atlanta, USA. Recommendations of the International Task Force for Disease Eradication. MMWR 1993; 42: 1-38.
5. Ottesen EA. Towards elimination of lymphatic filariasis. In Infectious Diseases and Public Health Angelico M and Rocchi G (eds.). Balaban Publishers, Tel Aviv, 1998: 58-64.
6. National Filariasis Control Programme Operational Manual. Directorate, National Malaria Eradication Programme, Delhi 1995.
7. World Health Organization. Lymphatic filariasis: The disease and its control. World Health Organ; 1992. Tech Rep Ser 821.
8. Ramaiah KD, Ramu K, Guyatt H, Vijayakumar KN and Pani SF. Direct and indirect costs of acute form of lymphatic filariasis in rural areas in Tamil Nadu, South India. Trop Med Int Hlth 1998; 3:108-115.
9. Pani SP, Yuvaraj J, Vanamail P and et al. Episodic adenolymphangitis and lymphoedema in patients with bancroftian filariasis. Trans R Sac Trop Med Hyg 1995; 89: 211-214.
10. Ramaiah KD, Das PK, Michael E and Guyatt H. Economic burden of lymphatic filariasis in India. Parasitol Today 2000; 16: 251-253.
11. Seim AR, Dreyer G and Addiss DG. Controlling morbidity and interrupting transmission: twin pillars of lymphatic filariasis elimination. Revista da Sociedade Brasileria de Medicina Tropical 1999; 32: 325-328.15.
12. Shenoy RK, Kumaraswami V, Suma TK, Raj an K and Radhakuttyamma G. A double blind placebo controlled study of the efficacy of oral penicillin, diethylcarbamazine or local treatment of the affected limb in preventing acute adenolymphangitis in lymphoedema caused by brugian filariasis. Ann Trop Med Parasitol 1999; 93: 367-377.
13. Gyapong JO, Gyapong M, Evans DB, Aikins MK and Adjei S. The economic burden of lymphatic filariasis in northern Ghana. Ann Trop Med Parasitol 1996; 90: 39-48.
14. Ramaiah KD, Vijayakumar KN, Ramu K, Pani SP and Das PK. Functional impairment caused by lymphatic filariasis in rural areas of south India. Trop Med Int Hlth 1997; 2: 832-838.
15. Dreyer G, Noroes J and Addiss D. The silent burden of sexual disability lymphatic filariasis. Acta Tropica 1997; 63: 57-60.
16. Ramaiah KD and Kumar KNV. Effect of lymphatic filariasis on school children. Acta Tropica. 2000; 76: 197-199.
17. Witt C and Ottesen EA. Lymphatic filariasis: an infection of childhood. Trop Med Int Hlth 2001; 6: 582-606.
18. Lammie PI, Reiss MD, Dimock KA, Streit TG, Roberts IM and Eberhard ML. Longitudinal analysis of the development of filarial infection and antifilarial immunity in a cohort of Haitian children. Am J Trop Med Hyg 1998; 59: 217-221.
19. Dreyer G, Noroes J, Addiss D, Santos A, Medeiros Z and Figueredo-Silva J, Bancroftian filariasis in a paediatric population: a ultrasonographic study. Trans R Sac Trop Med Hyg 1999; 93: 633-636.
20. Freedman DO, Bui T, de Almeida Filho PJ et al. Lymphoscintigraphic assessment of the effect of diethylcarbamazine treatment on lymphatic damage in human bancroftian filariasis. Am J Trop Med Hyg 1995; 52: 258-261.
21. Shenoy RK, John A, Hameed S, Suma T K and Kumaraswami V. Apparent failure of ultrasonography to detect adult worms of Brugia malayi. Ann Trop Med Parasitol 2000; 94: 77-82.
22. Dreyer G and Ottesen EA, Galdiono. Renal abnormalities in microfilaraemic patients with bancrofti an filariasis. Am J Trop Med Hyg 1992; 46: 745-749.
23. Noroes J, Addiss D, Amaral F, Coutinho A, Medeiros Z and Dreyer G. Occurrence of adult Wuchereria bancrofti in the scrotal area of men with microfilaraemia. Trans R Soc Trop Med Hyg 1996; 90: 55-56.
24. Freedman DO, de Alemeida Filho PI, Besh S, Maia e Silva MC, Braga C and Maciel A. Lymphoscintigraphic analysis of lymphatic abnormalities in symptomatic and asymptomatic human filariasis. J Infect Dis 1994; 170: 927-933.
25. Shenoy RK, Sandhya K, Suma TK and Kumaraswami V. A Preliminary study of filariasis related acute adenolymphangitis with special reference to precipitating factors and treatment modalities. SE Asian J Trop Med Pub Hlth 1995; 26: 301-305.
26. Suma TK, Shenoy RK, Varghese J, Kuttikkal VV and Kumaraswami V. Estimation of ASO titer as an indicator of streptococcal infection precipitating acute adenolymphangitis in brugian lymphatic filariasis. SE Asian J Trop Med Pub Hlth 1997; 28: 826-830.
27. Vincent AL, Urena-Rojas CA, Ayoub EM, Ottesen EA and Harden EG. Filariasis and erisipela in Santo Dominigo. J Parasitol 1998; 84: 557-61.
28. Olszewski WL and Jamal S. Skin bacterial factor in progression of filarial lymphoedema. Lymphology 1994; 27: 148-149.
29. Olszewski WL, Jamal S, Manokaran G et al. Bacteriologic studies of skin, tissue fluid, lymph and lymph nodes in patients with filarial lymphoedema. Am J Trop Med Hyg 1997; 57: 7-15.
30. Olszewski WL, Jamal S, Lukomska B, Kubicka U and Manokaran G. Skin changes in filarial and non-filarial lymphoedema of the lower extremities. Trop Med Parasitol 1993; 44: 40-44.
31. Shenoy RK, Suma TK, Rajan K and Kumaraswami V. Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Ann Trop Med Parasitol 1998; 92: 587-594.
32. Maizels RM and Lawrence RA. Immunological tolerance: The key feature in human filariasis? Parasitol Today 1991; 7: 271-276
33. King CL and Nutrnan TB. Regulation of the immune response in lymphatic filariasis and onchocerciasis. Parasitol Today 1991; 7: A54-A58
34. Maizels RM, Sartono E, Kurniawan A, Partono F, Selkirk ME and Yazdanbakhsh. T-cell activation and the balance of antibody isotypes in human lymphatic filariasis. Parasitol Today 1995; 11: 50-56
35. Keiser PB and Nutman TB. Update on lymphatic filarial infections. Cur T Infect Dis Reports 2002; 4: 65-69
36. Weil GJ, Ramzy RMR, Chandrashekhar R, Gad AM, Lowrie JR, RC and Faris R. Parasite antigenaemia without microfilaraemia in bancroftian filariasis. Am J Trop Med Hyg 1996; 55: 333-337.
37. Addiss DG and Dreyer G. Treatment of lymphatic filariasis. In: TB Nutman (ed.). Lymphatic Filariasis, Imperial College Press, London, 2000; 151-199.
38. Ottesen EA. Immunopathology of lymphatic filariasis in man. Springer Semin Immunopathol 1980; 2: 373-385.
39. Partono F. The spectrum of diseases in lymphatic filariasis. Ciba Foundation Sym 1987; 127: 15-31.
40. Dreyer G, Medeiros Z, Netto MJ, Leal NC, Gonzaga de Castro L and Peissens WF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg 1999; 93: 413-417.
41. Panicker KN and Sebasan S. Socioeconomic perspectives. Miscellaneous publications of VCRC. 1990; 16: 42-47.
42. Suma TK, Shenoy RK and Kumaraswami V. Efficacy and sustainability. of foot-care 2 programme in preventing acute attacks of adenolymphangitis (ADL) in brugian filariasis. Trop Med Int Hlth 2002; 7 (in press).
43. Kumaraswami V. The clinical manifestations of Lymphatic Filariasis. In: TB Nutman (ed.). Lymphatic Filariasis, Imperial College Press, London, 2000; 103-125.
44. Shenoy RK, Varghese J, Kuttikkal VV and Kumaraswami V. The efficacy, tolerability and safety of diethylcarbamazine-fortified salt in the treatment of microfilaraemia of brugian filariasis: an open, hospital-based study. Ann Trop Med Parasitol 1998; 92: 285-293.
45. Burri H, Loutan L, Kumaraswami V and Vijayasekaran V. Skin changes in chronic lymphatic filariasis. Trans R Soc Trop Med Hyg 1996; 90: 671-674.
46. World Health Organization. Informal consultation on evaluation of morbidity in lymphatic filariasis. Mimeographed document. WHO/TDR/FIL/ 92.3.1, Madras, 1992.
47. Dreyer G, Noroes J, Figueredo-Silva and Piessens WF. Pathogenesis of lymphatic disease in bancroftian filariasis. Parasitol Today 2000; 16: 544-548.
48. Andrade LA, Medeiros Z, Pires ML et al. Comparative efficacy of three different diethylcarbamazine regimens in lymphatic filariasis. Trans R Soc Trop Med Hyg 1995; 89: 319-321.
49. Shenoy RK, Kumaraswami V, Rajan K, Thankom S and Jalajakumari. A comparative study of the efficacy and tolerability of single and split doses of ivermectin and diethylcarbamazine in periodic Brugian filariasis. Ann Trop Med Parasitol 1993; 87: 459-467.
50. Ottesen EA. Towards eliminating lymphatic filariasis In: TB Nutman (ed.). Lymphatic Filariasis, Imperial College Press, London, 2000; 201-215.
51. Noroes J, Dreyer G, Santos A, Mendes VG, Medeiros Z and Addiss D. Assessment of efficacy of diethylcarbamazine on adult Wuchereria bancrofti in vivo. Trans R Soc Trop Med Hyg 1997; 91: 78-81.
52. Freedman DO, Plier DA, de Almeida AB, de Oliveira AL, Miranda J and Braga C. Effect of aggressive prolonged diethylcarbamazine therapy on circulating antigen levels in bancroftian filariasis. Trop Med Int Hlth 2002; 6: 37-41
53. Ottesen EA, Duke BOL, Karam M and Bebehani K. Strategies and tools for the control/elimination of lymphatic filariasis. Bull World Health Organ 1997; 75: 491-503.
54. Ottesen EA The global programme to eliminate lymphatic filariasis. Ann Trop Med Int Hlth 2000; 5: 591-594.
55. Dreyer G, Addiss D, Noroes J, Amaral F, Rocha A and Coutinho A. Direct assessment of the adulticidal efficacy of repeat high-dose ivermectin in bancroftian filariasis. Trop Med Int Hit 1996; 1: 427-432.
56. Jayakody RL, De Silva CSS, Weerasinghe WMT. Treatment of bancroftian filariasis with albendazole: evaluation of efficacy and adverse reactions. Trop Bio Med. 1993; 10: 19-24.
57. Shenoy RK, John A, Babu BS, Suma TK, and Kumaraswami V. Two-year follow-up of the of microfilaraemia of asymptomatic brugian filariasis, after treatment with two, annual, single doses of ivermectin, diethylcarbamazine or albendazole in various combinations. Ann Trop Med Parasitol 2000; 94: 607-614.
58. Olszewski WL, Tripathi FN, Manokaran G et al. Mycotic flora of legs with filarial lymphoedema. Progress in lymphology XVII - Proceedings of the 17th Int. Congr. of Lymphol., Chennai, India, 19-25 September, 1999, 141-143.
59. Suma TK, Shenoy RK and Kumaraswami V. Efficacy and sustainability of foot-care programme in preventing acute attacks of adenolymphangitis (ADL) in brugian filariasis. Trop Med Int Hit 2002; 7 (in press).
60. Shenoy RK. Lymphatic filariasis in children. Ind J Lymphol 2002; 1 (in press)
61. Pani SP and Lall R. Clinical features, pathogenesis and management of lymphatic filariasis. ICMR Bull. 1998; 28: 41-51.
62. Jamal Sand and Pani SP. Filarial lymphoedema - Reduction by surgery immediate and late results. Progress in lymphology xvn - Proceedings of the 17th Int. Congr. of Lymphol., Chennai, India, 19-25 September, 1999, 147-150.
63. Casley-Smith JR. Management of lymphoedema in India - A suggested protocol for prevention and treatment. Progress in lymphology XVII - Proceedings of the 17th Int. Congr. of Lymphol., Chennai, India, 19-25 September, 1999, 151-154.